Moderna, Inc. (MRNA)

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of $9.56 billion. The enterprise value is $783.38 million.

Market Cap	9.56B
Enterprise Value	783.38M

Important Dates

The next confirmed earnings date is Thursday, May 1, 2025, before market open.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Moderna has 386.62 million shares outstanding. The number of shares has increased by 0.52% in one year.

Current Share Class	386.62M
Shares Outstanding	386.62M
Shares Change (YoY)	+0.52%
Shares Change (QoQ)	-3.51%
Owned by Insiders (%)	6.59%
Owned by Institutions (%)	73.32%
Float	360.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.93
Forward PS	4.40
PB Ratio	0.88
P/TBV Ratio	0.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.07.

Current Ratio	3.67
Quick Ratio	3.45
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-164.38

Financial Efficiency

Return on equity (ROE) is -28.77% and return on invested capital (ROIC) is -18.44%.

Return on Equity (ROE)	-28.77%
Return on Assets (ROA)	-15.14%
Return on Invested Capital (ROIC)	-18.44%
Return on Capital Employed (ROCE)	-33.05%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.20
Inventory Turnover	37.66

Taxes

Income Tax	-46.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.18% in the last 52 weeks. The beta is 2.23, so Moderna's price volatility has been higher than the market average.

Beta (5Y)	2.23
52-Week Price Change	-76.18%
50-Day Moving Average	31.24
200-Day Moving Average	56.42
Relative Strength Index (RSI)	36.68
Average Volume (20 Days)	10,201,528

Short Selling Information

The latest short interest is 49.80 million, so 12.88% of the outstanding shares have been sold short.

Short Interest	49.80M
Short Previous Month	46.88M
Short % of Shares Out	12.88%
Short % of Float	13.80%
Short Ratio (days to cover)	5.11

Income Statement

In the last 12 months, Moderna had revenue of $3.24 billion and -$3.56 billion in losses. Loss per share was -$9.28.

Revenue	3.24B
Gross Profit	-2.77B
Operating Income	-3.95B
Pretax Income	n/a
Net Income	-3.56B
EBITDA	-3.76B
EBIT	-3.95B
Loss Per Share	-$9.28

Balance Sheet

The company has $7.03 billion in cash and $747.00 million in debt, giving a net cash position of $8.77 billion or $22.69 per share.

Cash & Cash Equivalents	7.03B
Total Debt	747.00M
Net Cash	8.77B
Net Cash Per Share	$22.69
Equity (Book Value)	10.90B
Book Value Per Share	28.24
Working Capital	5.89B

Cash Flow

In the last 12 months, operating cash flow was -$3.00 billion and capital expenditures -$1.05 billion, giving a free cash flow of -$4.06 billion.

Operating Cash Flow	-3.00B
Capital Expenditures	-1.05B
Free Cash Flow	-4.06B
FCF Per Share	-$10.49

Margins

Gross margin is -85.63%, with operating and profit margins of -121.91% and -110.04%.

Gross Margin	-85.63%
Operating Margin	-121.91%
Pretax Margin	-111.46%
Profit Margin	-110.04%
EBITDA Margin	-116.07%
EBIT Margin	-121.91%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.52%
Shareholder Yield	n/a
Earnings Yield	-37.27%
FCF Yield	-42.44%

Analyst Forecast

The average price target for Moderna is $54.47, which is 120.30% higher than the current price. The consensus rating is "Hold".

Price Target	$54.47
Price Target Difference	120.30%
Analyst Consensus	Hold
Analyst Count	20
Revenue Growth Forecast (5Y)	20.65%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 7.29 and a Piotroski F-Score of 2.

Altman Z-Score	7.29
Piotroski F-Score	2